Admissible multiarm stepped-wedge cluster randomized trial designs by Grayling MJ et al.
Received: 27 March 2017 Revised: 23 August 2018 Accepted: 10 October 2018
DOI: 10.1002/sim.8022
RE S EARCH ART I C L E
Admissible multiarm stepped-wedge cluster randomized
trial designs
Michael J. Grayling1 Adrian P. Mander1 James M. S. Wason1,2
1Hub for Trials Methodology Research,
MRC Biostatistics Unit, University of
Cambridge, Cambridge, UK
2Institute of Health and Society, Newcastle
University, Newcastle, UK
Correspondence
Michael J. Grayling, Hub for Trials
Methodology Research, MRC Biostatistics
Unit, University of Cambridge, Forvie Site,
Robinson Way, Cambridge CB2 0SR, UK.
Email: mjg211@cam.ac.uk
Funding information
Medical Research Council, Grant/Award
Number: MC_UP_1302/2; National
Institute for Health Research Cambridge
Biomedical Research Centre,
Grant/Award Number: MC_UP_1302/6
Numerous publications have now addressed the principles of designing, ana-
lyzing, and reporting the results of stepped-wedge cluster randomized trials. In
contrast, there is little research available pertaining to the design and analysis of
multiarm stepped-wedge cluster randomized trials, utilized to evaluate the effec-
tiveness ofmultiple experimental interventions. In this paper, we address this by
explaining how the required sample size in these multiarm trials can be ascer-
tained when data are to be analyzed using a linear mixed model. We then go on
to describe how the design of such trials can be optimized to balance between
minimizing the cost of the trial andminimizing some function of the covariance
matrix of the treatment effect estimates. Using a recently commenced trial that
will evaluate the effectiveness of sensor monitoring in an occupational therapy
rehabilitation program for older persons after hip fracture as an example, we
demonstrate that our designs could reduce the number of observations required
for a fixed power level by up to 58%. Consequently, when logistical constraints
permit the utilization of any one of a range of possible multiarm stepped-wedge
cluster randomized trial designs, researchers should consider employing our
approach to optimize their trials efficiency.
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1 INTRODUCTION
In a cluster randomized trial (CRT), groups of participants, not individuals, are randomized. The advantages this can bring
are today recognized as numerous. For example, CRTs can aid the control of contamination between participants and can
bring increased administrative efficiency, helping to overcome the barriers of recruiting large numbers of participants.1
Unfortunately, there are also several well-noted disadvantages to CRTs.2,3 Specifically, double blinding should ideally be
present in every trial; however, it is often impossible in CRTs. Moreover, missing data can quickly become a problem if
whole clusters are lost to follow-up.
Nevertheless, there has now been much work conducted on design and analysis procedures for CRTs. One type of CRT
that has received considerable attention recently, and which we focus on here, is the stepped-wedge (SW)-CRT (see, eg,
the work of Hussey and Hughes4). In a SW-CRT, an intervention is introduced over several time periods, and typically, all
*Abbreviations: CRT, cluster randomized trial; SW, stepped-wedge; MA, multiarm
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clusters receive the intervention by the end of the trial. Numerous potential advantages to this design have been forwarded.
Principally, all clusters receiving the intervention is advantageous if it is expected to domore good than harm. The design's
sequential implementation can also increase feasibility when there are logistical or practical constraints. However, these
alleged advantages have been disputed. Primarily, it has been argued that an intervention should not be implemented
in every cluster when it has not yet been proven to be effective. For brevity, we refer the reader elsewhere for further
discussion of these points.5-13
Methodological developments in this area include the work of Hussey and Hughes,4 who provided guidance on sample
size calculations for cross-sectional SW-CRTs analyzedwith a particular linearmixedmodel. Here, cross-sectional designs
refer to a scenario in which measurements are accrued on different participants in each time period. This work was later
built upon to establish a design effect for cross-sectional SW-CRTs14 and also to allow for transition periods and multiple
levels of clustering.15 Recently, similar results for cohort SW-CRTs, in which repeated measurements are accrued on a
single group of patients, have been presented.16 Finally, explanations on determining the sample size required by SW-CRTs
through simulation have also been presented.17
Thus, sample size determination for SW-CRTs has been well studied. However, the above articles only discuss sample
size calculations for a particular design. That is, a design with prescribed rules about how the experimental intervention
will be allocated across the clusters. Moreover, with the exception of the work of Baio et al,17 each paper deals only with a
specific analysis model. Addressing these limitations, recent research has ascertained optimal treatment allocation rules
for several general classes of cross-sectional SW-CRT design, analyzed with a highly flexible linear mixed model.18-20 A
subset of these results has subsequently been extended to cohort SW-CRTs.21 Nonetheless, there is still a need for guidance
on the optimal design of SW-CRTs with more specialized analysis models.
Furthermore, the above publications relate only to the design of two-arm SW-CRTs. Very little research has been con-
ducted on the design of CRTs with multiple experimental treatment arms, and in particular, scenarios in which clusters
may switch between interventions. We refer to such designs in this article as multiarm SW-CRTs (MA-SWs). Formu-
lae for the variance of the treatment effect estimators of several possible designs with three treatment arms, using a
specific linear mixed model for data analysis, are available.22 An additional paper recently proposed, and compared
the efficiencies of, several simple variants of the classical SW-CRT design that could be used to accommodate multiple
interventions.23 Finally, utilizing experimental design theory, the performance of several analysis models for the same
such MA-SW designs was recently examined.24 However, these are the only works that we are aware of pertaining to the
design of MA-SWs. This is perhaps surprising since several studies have recently been conducted in such a manner.25,26
Furthermore, intuitively, these designs could have numerous advantages that it would be beneficial to highlight. Explic-
itly, evaluating multiple interventions within the same CRT could bring the same sort of efficiency gains MA trials bring
to individually randomized studies.27 That is, the required number of clusters or observations could be reduced relative
to conducting several separate trials. Moreover, it could allow for a reduction in required funding as a consequence of
reduced administrative costs and may allow for the assessment of intervention interactions. Furthermore, one would
anticipate that such designs could on average decrease the time taken for each cluster to receive a particular intervention,
whichmay improve cluster and patient participation. However, the potential of MA-SWs can only be realized if we design
such studies effectively; poorly designed MA-SW trials would likely result in a poor answer being acquired to numerous
important questions.
Therefore, here, we first discuss how one can compute the sample size required by, and optimized treatment sequence
allocations for, a MA-SW design when a linear mixed model is used for data analysis. We then consider one particular
analysis model, and utilizing a recently undertaken trial as our principal motivation, discuss how large the efficiency
gains made using our methods could be in practice.
2 METHODS
2.1 Notation, hypotheses, and analysis
We designate a MA-SW as any trial conforming to the following requirements.
• The trial is carried out in C ≥ 2 clusters, over T ≥ 2 time periods, withm > 1 measurements made in each cluster in
each time period.
• In each time period, each cluster receives a combination of a set of D interventions (indexed by d = 0, … ,D − 1).
• The sequence of intervention allocations for each cluster is specified randomly.
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We make no assumptions about whether the m measurements from each time period are on different patients; a
cross-sectional design, or the same patients; a cohort design. We do not require each cluster to begin on, receive, or
conclude the trial on any particular intervention. We also do not enforce the usual one-directional switching associated
with conventional SW-CRTs, so as to allow for transitions between experimental interventions in any order, if this is
desired. As a consequence of this, the methodology we describe is applicable to the design of MA cluster randomized
crossover trials. We keep in mind, however, that each of the interventions must be received by at least one cluster in some
time period for its effect to be estimable.
Throughout, we assume that the accrued data from the trial will be normally distributed, and an identifiable linear
mixed model will be utilized for data analysis, denoted as
y = A𝜷 + Zu + 𝝐,
where
• y is the vector of responses;
• 𝜷 = (𝛽1, … , 𝛽p)⊤ is a vector of p fixed effects;
• A is the design matrix that links y to 𝜷;
• u is a vector of random effects, with u ∼ N(0,G), where G is a specified (assumed known) matrix;
• Z is the design matrix that links y to u;
• 𝝐 is a vector of residuals, with 𝝐 ∼ N(0,R), where R is a specified (assumed known) matrix.
We suppose that 𝜷 has been specified such that its first q, q ≤ p, elements, (𝛽1, … , 𝛽q)⊤, are our parameters of interest.
Typically, wemay have that q = D − 1, with these parameters representing either the direct effects of a set of experimental
interventions relative to some control or the direct effect of intervention arm d relative to intervention arm d − 1, for
d = 1, … ,D − 1. However, we do not require that this be the case. Then, we assume that we will test the following
one-sided hypotheses:
H0𝑓 ∶ 𝛽𝑓 ≤ 0, H1𝑓 ∶ 𝛽𝑓 > 0, 𝑓 = 1, … , q.
We note though that the determination of MA-SW designs for alternative hypotheses of interest, eg, two-sided
hypotheses, is also easily achievable by adapting what follows.
To test these hypotheses, following trial completion, we estimate 𝜷 using the maximum likelihood estimator of a linear
mixed model
?̂? =
(
𝛽1, … , 𝛽p
)⊤ = {A(ZGZ⊤ + R)−1A}−1A⊤(ZGZ⊤ + R)−1y.
Then,
cov(?̂?, ?̂?) = Λ = {A(ZGZ⊤ + R)−1A}−1.
We set ?̂?q = (𝛽1, … , 𝛽q)⊤ and denote the covariance matrix of ?̂?q by Λq. That is, cov(?̂?q, ?̂?q) = Λq.
Our conclusions are then based upon the following Wald test statistics:
Z𝑓 =
𝛽𝑓√
var(𝛽𝑓 )
= 𝛽𝑓Λ−1∕2[𝑓,𝑓 ] = 𝛽𝑓 I
1∕2
𝑓
, 𝑓 = 1, … , q.
Explicitly, we rejectH0f if Zf > e, for critical boundary e. Given e, we can determine for any vector of true fixed effects 𝜷q
the probability each particular H0f is rejected, and the probability we reject at least one of H01, … ,H0q, via the following
integrals:
ℙ(Reject H0𝑓 | 𝛽𝑓 ) =
∞
∫
e
𝜙(x, 𝛽𝑓 I1∕2𝑓 , 1)dx,
ℙ(Reject at least one of H01, … ,H0q|𝜷q) = 1 −
e
∫
−∞
· · ·
e
∫
−∞
𝜙{x, 𝜷q◦I1∕2, diag(I1∕2)Λqdiag(I1∕2)}dxq· · ·dx1.
Here,
• 𝜙(x,𝝁,Σ) is the probability density function of a multivariate normal distribution with mean 𝝁 = (𝜇1, … , 𝜇k)⊤ and
covariance matrix Σ, dim(Σ) = k × k, evaluated at vector x = (x1, … , xk)⊤;
• (a1, … , an)⊤ ◦ (b1, … , bn)⊤ = (a1b1, … , anbn)⊤;
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• I1∕2 = (I1∕21 , … , I
1∕2
q )⊤ is the elementwise square root of the vector of information levels for 𝜷q;
• diag(v) for a vector v indicates the matrix formed by placing the elements of v along the leading diagonal.
Determining an appropriate value for e depends uponwhether a correction formultiple testing is to be utilized.Without
such a correction, e can be chosen to control the per-hypothesis error rate to 𝛼 by setting e as the solution to
𝛼 =
∞
∫
e
𝜙(x, 0, 1)dx.
Alternatively, the familywise error rate, the probability of one or more false rejections, can be controlled, for example,
using the Bonferroni correction, which sets in this instance e to be the solution of
𝛼
q =
∞
∫
e
𝜙(x, 0, 1)dx.
The choice of whether to utilize a multiple testing correction is not a simple one, with much debate in the literature
around when it is necessary. It seems reasonable for MA-SWs, however, to extrapolate from previous discussions, and
note that one should correct in confirmatory settings but should not always feel the need to in exploratory settings.28
2.2 Power considerations
The above fully specifies a hypothesis testing procedure for a MA-SW. However, at the design stage, it is important to
be able to determine values of m, C, and T that provide both the desired per-hypothesis or familywise error rate and the
desired power. Here, we describe two types of power that could be required, since power is not a simple concept in MA
trials.
We suppose that power of at least 1 − 𝛽 is required either to reject each H0f (individual power) or at least one of
H01, … ,H0q (combined power), when 𝜷q = 𝜹 = (𝛿1, … , 𝛿q)⊤. The element 𝛿f here represents a clinically relevant
difference for the effect 𝛽 f. Using our notation from earlier, these requirements can be written as
min
𝑓∈{1,… ,q}
ℙ(Reject H0𝑓 |𝛿𝑓 ) ≥ 1 − 𝛽,
ℙ(Reject at least one of H01, … ,H0q |𝜹) ≥ 1 − 𝛽.
The choice between these requirements should be made based on several considerations. The latter will likely require
smaller sample sizes; however, it would leave a trial less likely to reject all false null hypotheses. Therefore, trialists must
weigh up the cost restrictions and goals of their trial.
2.3 Design specification
We can now return to our considerations on determining appropriate values for m, C, and T. We must also determine
as part of the same process a matrix X that indicates the planned allocation of interventions to each cluster across the
time periods. Extending the notation commonly utilized for SW-CRTs, X is a C × T matrix, with Xij indicating which
intervention(s) cluster i receives in time period j. If only a single intervention is given to each cluster in each time period,
then Xij will be a single number. Otherwise, it may be some combination of values, indicating allocation to multiple
interventions. With this, it will now be useful to denote the design utilized by a trial by 𝒟 = {m,C,T,X}, and the
associated covariance matrix for 𝜷q by Λ𝒟 . Our goal is then to optimize𝒟 .
Most of the works on sample size determination for SW-CRTs pre-supposes that two of the three parameters m, C,
and T are fixed (with one usually T) and then looks to identify the third. In addition, the matrix X is usually specified,
if not explicitly (in the case where C and T are fixed), then through some rule such as balanced stepping. Here, we take
an alternate approach to the determination of the preferred design. We assume that a set of allowed values for T has
been specified, 𝔗 = {T1, … ,T|𝔗|}. We then suppose that sets of allowed values for C, for each element of 𝔗, have been
specified. We denote these by ℭ = {ℭT1 , … ,ℭT|𝔗|}, with ℭTi = {C1, … ,C|ℭTi |}. Furthermore, we suppose that, for each
allowed C,T combination, a set of allowed values for m has been provided; 𝔐C,T = {m1, … ,m|𝔐C,T |}. We then take
𝔐 = {𝔐C,T ∶ T ∈ 𝔗,C ∈ ℭT}. We allow for such an interrelated specification of the values form,C, and T to cover many
possible design scenarios. For example, increasing the value of Tmay mean logistical constraints force only lower values
of m and C to be possible. In actuality, it is likely a trialist would not need such a complicated structure. For example,
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the classical case of fixed T and m, searching for the correct value for C, would require only 𝔗 = {T},𝔐C,T = {m}, and
ℭ = {ℭT}, with ℭT = {2, … ,Cmax}, and Cmax some suitably large value.
Finally, for each C,T combination, we also specify a set of allowed X, which we denote by𝔛C,T . Similar to the above, we
then take 𝔛 = {𝔛C,T ∶ T ∈ 𝔗,C ∈ ℭT}. Shortly, we will describe several possible ways in which 𝔛C,T could be specified.
Now, with 𝔗, ℭ,𝔐, and 𝔛 chosen, formally, our set𝔇 of all allowed possible designs is
𝔇 = {𝒟 ∶ T ∈ 𝔗,C ∈ ℭT ,m ∈𝔐C,T ,X ∈ 𝔛C,T}.
2.4 Admissible design determination
As was discussed, previous research has assessed what is the optimal SW-CRT design to maximize power in an array of
possible design scenarios. This was achieved by developing formulae for the efficiency of designs under particular linear
mixed models. Such considerations could, in theory, be extended to MA-SWs or to alternate analysis models. However,
it is not practical to conduct such derivations for every value of D or every analysis model that may need to be utilized.
In addition, it is not actually necessary following specification of the set 𝔇: preferable designs can be determined using
exhaustive or stochastic heuristic searches.
Explicitly, for some𝔇, modern computing makes an exhaustive search possible using parallelization. Alternatively, in
the case where C and T are fixed (either in advance or after some initial design identification), we can employ a different
method to determine our final design: a stochastic search. This is sensible when, evenwithC and T fixed, the design space
𝔇 remains large. Here, we accomplish this optimization using CEoptim in R.29
To perform a search, an optimality criterion is required. Previous research on SW-CRTs has focused on determining
designs that minimize the variance of the treatment effect estimator. Here, we extend this to consider designs that min-
imize some weighted combination of a trial cost function and some factor formed from the covariance matrix of the
treatment effect estimators, Λ𝒟 .
Specifically, we allocate a function 𝑓 (𝒟 ) that sets the cost associatedwith a trial using design𝒟 . This could be as simple
as the required number of observations, or something more complex that factors in the speed the interventions would
need to be rolled out according to X, for example.
ForΛ𝒟 , numerous possible optimality criteria have been suggested in the literature. We consider D-, A-, and E-optimal
designs, which all have a long history within the field of experimental design. D-optimality corresponds to minimizing
the determinant of Λ𝒟 , det(Λ𝒟 ). This can be interpreted as minimizing the volume of the confidence ellipsoid for the
𝛽 f. For A-optimality, the average value of the elements along the diagonal of Λ𝒟 , tr(Λ𝒟 )∕q, is minimized. That is, we
minimize the average variance of the 𝛽 f. Finally, in E-optimality, we minimize the maximal value of the elements along
the diagonal of Λ𝒟 , maxDiag(Λ𝒟 ), ie, we minimize the most extreme, or largest, of the variances of the 𝛽 f. We refer the
reader elsewhere for greater detail on these criteria.30,31
Then, for example, our admissible design using the D-optimality criteria will be the𝒟∗, conforming to the trials power
requirements, that minimizes
w 𝑓 (𝒟∗) −min𝒟∈𝔇𝑓 (𝒟 )max𝒟∈𝔇𝑓 (𝒟 ) −min𝒟∈𝔇𝑓 (𝒟 )
+ (1 − w)
det(Λ𝒟∗ ) −min𝒟∈𝔇 det(Λ𝒟 )
max𝒟∈𝔇 det(Λ𝒟 ) −min𝒟∈𝔇 det(Λ𝒟 )
. (1)
Here, 𝑓 (𝒟∗) and det(Λ𝒟∗ ) are rescaled precisely because they exist on different scales. Additionally, 0 ≤ w ≤ 1 is
the weight given to minimizing the trials cost relative to the efficiency of Λ𝒟 . Note that the case w = 1 should often
be ignored since many designs will likely share equal values of 𝑓 (𝒟 ). Admissible designs using the A- or E-optimality
criteria are formed by replacing det(Λ𝒟 ) in the above by tr(Λ𝒟 )∕q or maxDiag(Λ𝒟 ), respectively.
Note that, if all of the designs in𝔇 cannot attain the desired power, no admissible design will exist. To counteract this,
we can increase the value of 𝛽. In an extreme scenariowhere no designwill likelymeet any reasonable power requirement,
we can set 𝛽 = 1 and w = 0 and look to determine the design𝒟 that simply minimizes some function of Λ𝒟 .
Finally, the rescaling in Equation (1) is only possible in the case of an exhaustive search where minimal and maximal
values can be identified. Therefore, in the case of a stochastic search, we consider only meeting the conventional D-, A-
and E-optimality criteria, without rescaling.
2.5 Example trial design scenarios and associated linear mixed model
In what follows, we frame our examples within the context of studies in which there is a nested natural order upon the
D interventions. That is, as in the works of Chinbuah et al25 and Pol et al,26 for d = 1, … ,D − 1, intervention d consists
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of intervention d − 1 and some additional factor (eg, intervention d may include additional components of some wider
multifaceted intervention over intervention d − 1). We therefore now, in all instances, enforce the restrictions that each
cluster receives only a single intervention in each time period and that, if a cluster receives intervention d in time period
j, it cannot receive interventions 0, … , d − 1 in time periods j + 1, … ,T. Relating this restriction to our matrix X, it
implies Xij ≥ Xij− 1 for j = 2, … ,T and i = 1 … ,C.
Our methodology for the determination of admissible MA-SW designs is now fully specified. Code to implement our
methods and replicate our results is available from https://github.com/mjg211/article_code. Next, several example trial
design scenarios are considered to demonstrate the efficiency gains our designs could bring. In each, we assume that
the goal is to compare the efficacy of intervention 1 to intervention 0, intervention 2 to intervention 1, and so on, giving
q = D − 1. Moreover, in all examples, the following linear mixedmodel, an extension of that used in the works of Girling
and Hemming19 and Hooper et al16 to a MA setting, is employed for data analysis
𝑦i𝑗k = 𝜇 + 𝜋𝑗 + 𝛽1𝕀{Xi𝑗 ≥ 1} + · · · + 𝛽D−1𝕀{Xi𝑗 ≥ D − 1} + ci + 𝜃i𝑗 + sik + 𝜖i𝑗k.
Here,
• 𝕀(x) is the indicator function on event x;
• yijk is the kth response (k = 1, … ,m), in the ith cluster (i = 1, … ,C), in the jth time period ( j = 1, … ,T);
• 𝜇 is an intercept term;
• 𝜋j is the fixed effect for the jth time period (with 𝜋1 = 0 for identifiability);
• ci is the random effect for cluster i, with ci ∼ N(0, 𝜎2c );
• 𝜃ij is a random interaction effect for cluster i and period j, with 𝜃i𝑗 ∼ N(0, 𝜎2𝜃 );
• sik is a random effect for repeated measures in individual k from cluster i, with sik ∼ N(0, 𝜎2s );
• 𝜖ijk is the residual error, with 𝜖i𝑗k ∼ N(0, 𝜎2𝜖 ).
Thus, we specify our model to be applicable to a cohort MA-SW trial. We can then recover a model appropriate for a
cross-sectional design by setting 𝜎2s = 0. Note that, by the above, the variance of response yijk is 𝜎2 = 𝜎2c + 𝜎2𝜃 + 𝜎
2
s + 𝜎2𝜖 . In
Section 3, we will make reference to the following three correlation parameters:
• 𝜌0 = (𝜎2c + 𝜎2𝜃 )∕𝜎2: the within-period correlation (the correlation between the responses from two distinct individuals,
in the same cluster, in the same time period);
• 𝜌1 = 𝜎2c ∕𝜎2: the interperiod correlation (the correlation between the responses from two distinct individuals, in the
same cluster, in distinct time periods);
• 𝜌2 = (𝜎2c + 𝜎2s )∕𝜎2: the individual autocorrelation (the correlation between the responses from the same individual in
distinct time periods).
Finally, note that we also restrict the sets 𝔛C,T in all instances to those X, which imply the above model is identifiable,
which can be verified for any X using the implied design matrix A. However, for brevity, we do not explicitly state this
requirement in our forthcoming specifications of the sets 𝔛C,T .
3 RESULTS
3.1 D = 2: Girling and Hemming (2016) and Thompson et al (2017)
It was previously demonstrated that the efficiency of a conventional SW-CRT (ie, the case D = 2), analyzed with the
above linear mixed model, could be assessed using the cluster mean correlation, given by19
E(𝜌) = mT𝜌1 + (mT − 1)𝜌 ,
where 𝜌 is the intracluster correlation for the means of the observations at each time-point, in each cluster. The optimal X
matrices to minimize the variance of 𝛽1, when T = 6 and C = 10, were also provided in this paper. We now demonstrate
how our exhaustive search procedure can identify such optimal designs.
First, we setℑ = {6} andℭ = {ℭ6} = {10}. We place no further restrictions on𝔛10,6 than those outlined in Section 2.5,
and thus,
𝔛6,10 = {X ∶ dim(X) = 6 × 10,Xi𝑗 ≥ Xi𝑗−1 for 𝑗 = 2, … , 6 and i = 1… , 10}.
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To minimize var(𝛽1), we take w = 0 and 𝛽 = 1. Since D = 2, the D-, A-, and E-optimality criteria are equivalent,
and we do not need to specify a multiple comparison correction. While with 𝛽 = 1, our choices for 𝛼, 𝜹, and desire for
individual or combined power are irrelevant. Finally, for simplicity, we reduce our model to that from the work of Hussey
and Hughes4 by supposing that 𝜎2
𝜃
= 𝜎2s = 0. Then, 𝜌 = 𝜌0 = 𝜌1 = 𝜌2 is the conventional intracluster correlation
associated with cross-sectional SW-CRTs. Accordingly, to find optimal designs for different ranges of E(𝜌), as in Girling
the work of and Hemming,19 we take as an example 𝜎2 = 1,𝔐6,10 = {10}, and set 𝜌 as those values that imply E(𝜌) ∈
{0.1, 0.15, 0.3, 0.45, 0.75, 0.9}.
The results of our exhaustive searches are shown in Table 1. In each instance, the optimal design is, as would be
expected, identical to that found previously. We have thus confirmed the ability of our search procedure to easily identify
optimal designs for a given set of input parameters and chosen linear mixed model. Of course, in this scenario, it would
likely, in practice, be easier to utilize the methodology of Girling and Hemming.19
More recently, Thompson et al20 demonstrated that, when 𝜎2
𝜃
= 𝜎2s = 0, if an equal number of clusters must be allocated
to each sequence, then the optimal number of sequences to utilize would be
F(𝜌) = 1
1 −
√
E(𝜌)
.
We now verify their findings by restricting our set 𝔛6,10 as follows:
𝔛6,10 = {X ∶ dim(X) = 6 × 10,Xi𝑗 ≥ Xi𝑗−1 for 𝑗 = 2, … , 6 and i = 1… , 10,
(Xi1, … ,Xi6) = (Xi′1, … ,Xi′6) for a values of i′ = 1, … , i − 1, i + 1, … , 10 and i = 1, … , 10},
where a can be any value such that C∕a is an integer.
TABLE 1 Optimal allocation matrices for cross-sectional designs
with D = 2. The optimal allocation matrices in the case ℑ = {6},
ℭ = {ℭ6} = {10},𝔐 =𝔐6,6 = {10}, and 𝜎2 = 1, with w = 0 and
𝛽 = 1 are shown for a range of possible values of E(𝜌). No restrictions
are placed on 𝔛 other than the identifiability of Equation (1). Each
allocation matrix was identified via our exhaustive search method
and matches that identified by previous research
Factor Results
E(𝜌) 0.1 0.15 0.3
X
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 1
0 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 1 1
0 0 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
E(𝜌) 0.45 0.75 0.9
X
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 1
0 0 0 0 1 1
0 0 1 1 1 1
0 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 1
0 0 0 0 1 1
0 0 0 1 1 1
0 0 0 1 1 1
0 0 1 1 1 1
0 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 0
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 1 1
0 0 0 1 1 1
0 0 0 1 1 1
0 0 1 1 1 1
0 1 1 1 1 1
0 1 1 1 1 1
1 1 1 1 1 1
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
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For the design parameters utilized to construct Table 1, we repeated our exhaustive searches but with themodified𝔛6,10
given above. For E(𝜌) ∈ {0.10, 0.15, 0.30}, we found that the optimal X was
X =
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
.
This should not surprise us, as for E(𝜌) ∈ {0.10, 0.15, 0.30}, we have F(𝜌) ∈ {1.46, 1.63, 2.21} to 2 decimal places, and
the X listed above is one of the few matrices belonging to the modified 𝔛6,10 that utilizes two sequences.
In contrast, for E(𝜌) = 0.45, we find F(𝜌) = 3.04. However, forC = 10, the only way equal allocation to sequences can be
achieved is to utilize either two or five sequences. It should therefore not surprise us that the optimal X was identified as
X =
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 1 1 1
0 0 0 1 1 1
0 1 1 1 1 1
0 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
,
which uses five sequences. Finally, for E(𝜌) ∈ {0.75, 0.9}, we have F(𝜌) ∈ {7.46, 19.49}, and the optimal X was again
one that employs five sequences.
3.2 D = 2: sensitivity of the optimal designs to the variance parameter specification
It is important to note that our admissible design determination procedure, like the articles on optimal SW-CRTs that have
come before, is dependent upon the specification of all relevant variance parameters. It is for this reason that Girling and
Hemming19 assessed the sensitivity of the performance of their optimized designs to the value of E(𝜌), via a simulation
study in which E(𝜌) was specified using a prior.
Here, we consider an alternative approach to visualizing the performance of optimal designs across possible values
of the variance parameters. First, in Figure 1, for w = 0, 𝛽 = 1, 𝜎2
𝜃
= 𝜎2s = 0, ℑ = {6}, ℭ = {ℭ6} = {10}, and
𝔐 = 𝔐10,6 = {10}, we present the locations on an equally spaced grid within (𝜎2c , 𝜎2𝜖 ) ∈ [0.001, 0.25] × [0.25, 4] at
which we identified various designs to be optimal using an exhaustive search (placing no restrictions on𝔛6,10). In total, 11
designs were found to be optimal for at least one (𝜎2c , 𝜎2𝜖 ) combination. We list these in full in the Online Supplementary
Material. It would be reasonable to be troubled by this result, as it suggests, a design that we believe to be optimal may
not in reality be optimal if the variance parameters are even minorly misspecified.
We can, however, inspect how large our concern should be by examining the performance of any of these optimal
designs across the possible values of the variance parameters, relative to the performance of the true optimal design at
each point. That is, we inspect the ratio of the variance of the intervention effect estimate of a particular design to that
of the optimal design at each (𝜎2c , 𝜎2𝜖 ) combination. We present such an evaluation in Figure 2 for the following design
matrices:
X1 =
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
, X2 =
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 0
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 1 1
0 0 0 1 1 1
0 0 0 1 1 1
0 0 1 1 1 1
0 1 1 1 1 1
0 1 1 1 1 1
1 1 1 1 1 1
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
,
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FIGURE 1 Optimal allocation matrices for cross-sectional designs with D = 2. The optimal allocation matrices in the case ℑ = {6},
ℭ = {ℭ6} = {10},𝔐 =𝔐10,6 = {10}, and 𝜎2 = 1, with w = 0 and 𝛽 = 1 are shown for a range of possible combinations of (𝜎2c , 𝜎2𝜖 ) ∈
[0.001, 0.25] × [0.25, 4]. No restrictions are placed on 𝔛 other than the identifiability of Equation (1). Each allocation matrix was identified via
our exhaustive search method [Colour figure can be viewed at wileyonlinelibrary.com]
which are Designs 8 and 3 from Figure 1, respectively. Asmust obviously be the case, the value of the ratio of the variances
is in all instances at least one. We observe that, with the matrix X1, the variance of the intervention effect estimate is
substantially larger than that for the optimal design when the values of 𝜎2c and 𝜎2𝜖 are misspecified, particularly when the
value of 𝜌 is in fact large. In contrast, using the matrix X2 retains efficient performance in many instances. However, if 𝜌
is small then the variance of the intervention effect provided by this design is still more than 40% larger than that of the
optimal design.
3.3 D = 2: Li et al (2018)
Li et al21 recently extended the results in the work of Lawrie et al18 to cohort SW-CRTs. Specifically, they considered
a case in which all clusters have to begin in the control condition (intervention 0) and conclude in the experimental
(intervention 1). They then demonstrated that the optimal X could be specified by ensuring that the proportion, pt, of
clusters allocated to a sequence with t ones preceded by T − t zeros satisfies
p1 = pT−1 =
𝜓 + 3𝜉
2𝛾 ,
pt =
𝜉
𝛾
, for t = 2, … ,T − 2,
where
𝜓 = 1 − (m − 1)𝜌0 − (m − 1)𝜌1 − 𝜌2,
𝜉 = (m − 1)𝜌1 + 𝜌2,
𝛾 = 𝜓 + T𝜉.
Here, we explore their findings for several example design scenarios, again via an exhaustive search. As above, we
consider the case in which ℑ = {6}, ℭ = {ℭ6} = {10}, and𝔐 = 𝔐10,6 = {10}, with 𝜎2 = 1, w = 0, and 𝛽 = 1. To
follow their restrictions on the allowed X, we enforce that
𝔛6,10 = {X ∶ dim(X) = 6 × 10,Xi𝑗 ≥ Xi𝑗−1 for 𝑗 = 2, … , 6 and i = 1, … , 10, Xi1 = 0 and XiT = 1 for i = 1, … ,C}.
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FIGURE 2 The ratio of the variance of the intervention effect when using design matrices X1 (top) and X2 (bottom) relative to the optimal
design (given in Figure 1) is shown for a range of possible combinations of (𝜎2c , 𝜎2𝜖 ) ∈ [0.001, 0.25] × [0.25, 4] [Colour figure can be viewed at
wileyonlinelibrary.com]
Then, we denote by pth = (p1, … , pT− 1)⊤ the vector of the pt for the theoretical optimal designs derived by Li et al,21
and we denote by pemp the vector of the empirical values of the pt for our identified optimal designs. Our findings are
presented in Table 2 for (𝜌0, 𝜌1, 𝜌2) ∈ {0.05, 0.1} × {0.001, 0.002} × {0.25, 0.5}. They illustrate one potential issue with
applying the results in the work of Li et al21 in practice that the theoretically optimal values of the pt will likely not be
achievable because C is an integer. However, it is clear that the empirical values of the proportions of clusters changing to
the experimental intervention in each time period are close to their theoretical values, even in this case where C is small.
3.4 D = 3: SO-HIP Study
The SO-HIP study is a cross-sectional MA-SW, with D = 3, to evaluate the effectiveness of sensor monitoring in an occu-
pational therapy rehabilitation program for older people after hip fracture. Specifically, arm 0 corresponds to providing
participantswith care as usual. Arm1 then involves the additional use of occupational therapywithout sensormonitoring,
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TABLE 2 Optimal allocation matrices for cohort designs with D = 2. The optimal allocation matrices in the case
ℑ = {6}, ℭ = {ℭ6} = {10},𝔐 =𝔐10,6 = {10}, and 𝜎2 = 1, with w = 0 and 𝛽 = 1 are shown for a range of possible
combinations of 𝜌0, 𝜌1, and 𝜌2. Restrictions are placed on 𝔛 such that Equation (1) is identifiable and that each cluster
must start in the control intervention (arm 0) and conclude in the experimental intervention (arm 1). Each allocation
matrix was identified via our exhaustive search method
Factor Results
𝜌0 0.050 0.050 0.050 0.050
𝜌1 0.001 0.001 0.002 0.002
𝜌2 0.250 0.500 0.250 0.500
X
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 1 1
0 0 0 1 1 1
0 0 1 1 1 1
0 1 1 1 1 1
0 1 1 1 1 1
0 1 1 1 1 1
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 1 1
0 0 0 1 1 1
0 0 0 1 1 1
0 0 1 1 1 1
0 1 1 1 1 1
0 1 1 1 1 1
0 1 1 1 1 1
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 1 1
0 0 0 1 1 1
0 0 1 1 1 1
0 1 1 1 1 1
0 1 1 1 1 1
0 1 1 1 1 1
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 1 1
0 0 0 1 1 1
0 0 0 1 1 1
0 0 1 1 1 1
0 1 1 1 1 1
0 1 1 1 1 1
0 1 1 1 1 1
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
p⊤th (0.30,0.08,0.08,0.08,0.30) (0.24,0.10,0.10,0.10,0.24) (0.29,0.08,0.08,0.08,0.29) (0.24,0.10,0.10,0.10,0.24)
p⊤emp (0.4,0.1,0.1,0.1,0.3) (0.3,0.1,0.2,0.1,0.3) (0.4,0.1,0.1,0.1,0.3) (0.3,0.1,0.2,0.1,0.3)
𝜌0 0.100 0.100 0.100 0.100
𝜌1 0.001 0.001 0.002 0.002
𝜌2 0.250 0.500 0.250 0.500
X
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 1 1
0 0 1 1 1 1
0 1 1 1 1 1
0 1 1 1 1 1
0 1 1 1 1 1
0 1 1 1 1 1
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 1 1
0 0 0 1 1 1
0 0 0 1 1 1
0 0 1 1 1 1
0 1 1 1 1 1
0 1 1 1 1 1
0 1 1 1 1 1
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 1 1
0 0 1 1 1 1
0 1 1 1 1 1
0 1 1 1 1 1
0 1 1 1 1 1
0 1 1 1 1 1
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 0 1
0 0 0 0 1 1
0 0 0 1 1 1
0 0 0 1 1 1
0 0 1 1 1 1
0 1 1 1 1 1
0 1 1 1 1 1
0 1 1 1 1 1
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
p⊤th (0.32,0.07,0.07,0.07,0.32) (0.26,0.10,0.10,0.10,0.26) (0.31,0.07,0.07,0.07,0.31) (0.26,0.10,0.10,0.10,0.26)
p⊤emp (0.4,0.1,0,0.1,0.4) (0.3,0.1,0.2,0.1,0.3) (0.4,0.1,0,0.1,0.4) (0.3,0.1,0.2,0.1,0.3)
in contrast to arm 2 that incorporates occupational therapy with cognitive behavioral therapy coaching using sensor
monitoring as a coaching tool. Thus, as discussed earlier, intervention d − 1 is nested within intervention d, for d = 1, 2.
SO-HIP plans to enroll six clusters (C = 6) and has six time periods (T = 6), with eight observations made per cluster
per period (m = 8), using the following matrix for treatment allocation:
X =
⎛⎜⎜⎜⎜⎜⎝
0 0 0 1 1 2
0 0 0 1 1 2
0 0 1 1 2 2
0 0 1 1 2 2
0 1 1 2 2 2
0 1 1 2 2 2
⎞⎟⎟⎟⎟⎟⎠
.
The trial has 𝜹 = (1.5𝜎, 0.75𝜎)⊤ and assumes that 𝜎2s = 𝜎2𝜃 = 0 and 𝜌( = 𝜌0 = 𝜌1 = 𝜌2) = 0.05. With this, when
𝜎2 = 1, using our methods described above, we can identify that the proposed design will have an individual power of
0.88 (𝛽 = 0.12) when the familywise error rate is controlled to 𝛼 = 0.05 using the Bonferroni correction. For further
information on this trial, see the published protocol.26
We now consider howmuch efficiency could be gained by utilizing an alternative design. We presume that, in the trial,
any number of time periods two through six could have been employed (ℑ = {2, … , 6}) and any number of clusters
two through six could have actually been utilized (ℭ = {ℭ2, … ,ℭ6}, with ℭT = {2, … , 6} for each T ∈ 𝔗). Finally, we
assume that the trials plan to recruit 48 patients in total from each cluster would allow𝔐C,T = {2, … , ⌊48∕T⌋}. Here,
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TABLE 3 Optimal allocation matrices for cross-sectional designs with D = 3. Several
optimal allocation matrices in the case ℑ = {2, … , 6}, ℭ = {ℭ2, … ,ℭ6}, ℭT = {2, … , 6},
𝔐C,T = {2, … , ⌊48∕T⌋}, 𝜎2 = 1, 𝜌 = 0.05, 𝛼 = 0.05 with the Bonferroni correction, and
𝛽 = 0.12 for the individual power when 𝜹 = (1.5𝜎, 0.75𝜎)⊤ are shown. Specifically, the
optimal design for the optimality criteria is given for w ∈ {0, 0.5}. No restrictions are placed
on 𝔛 other than the identifiability of Equation (1). Each allocation matrix was identified via
our exhaustive search method. The utilized design is also shown for comparison
Design
Factor Proposed D/A/E-Optimal: w= 0 D/A/E-Optimal: w= 0.5
C 6 6 6
T 6 6 5
m 8 8 4
X
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 1 1 2
0 0 0 1 1 2
0 0 1 1 2 2
0 0 1 1 2 2
0 1 1 2 2 2
0 1 1 2 2 2
⎞⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 1
0 0 0 0 1 1
0 0 0 1 1 2
0 1 1 2 2 2
1 1 2 2 2 2
1 2 2 2 2 2
⎞⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 1 1 1
0 0 1 1 1
1 1 1 2 2
1 1 2 2 2
2 2 2 2 2
2 2 2 2 2
⎞⎟⎟⎟⎟⎟⎟⎠
ℙ(Reject H01|𝛿1) 1.000 1.0000 (±0%) 0.9937 (−0.6%)
ℙ(Reject H02|𝛿2) 0.8815 0.9878 (+12.1%) 0.8818 (±0%)
𝑓 (𝒟 ) 288 288 (±0%) 120 (−58.3%)
det(Λ𝒟 ) 3.090 × 10−3 9.990 × 10−4 (−67.7%) 6.377 × 10−3 (+106.4%)
(D − 1)−1tr(Λ𝒟 ) 5.696 × 10−2 3.175 × 10−2 (−44.3%) 8.508 × 10−2 (+49.4%)
maxDiag(Λ𝒟 ) 5.696 × 10−2 3.175 × 10−2 (−44.3%) 1.132 × 10−1 (+98.8%)
we enforce that
𝔛C,T = {X ∶ dim(X) = C × T,Xi𝑗 ≥ Xi𝑗−1 for 𝑗 = 2, … ,T and i = 1… ,C}.
Taking our cost function to be the total number of observations, 𝑓 (𝒟 ) = mCT, we present several admissible designs in
Table 3. Explicitly, in this case, we find that the optimal designs when using the D-, A-, and E-optimality criteria coincide
for w = 0 and w = 0.5. Note that we also considered the optimal designs for w = 1 − 10−4, but they were found to be
identical to those for w = 0.5.
We can see that the individual power of the trial could be increased by as much as 12.1%, as a result of reducing the
maximum value of the variances of the treatment effect estimators by 44.3% (w = 0). Alternatively, the individual power
could be maintained and the required number of observations reduced by up to 58.3% (w = 0.5).
Now, in Table 4, we present corresponding evaluations, but with further restrictions placed on the sets𝔛C,T , as follows:
𝔛C,T = {X ∶ dim(X) = C × T,Xi𝑗 ≥ Xi𝑗−1 for 𝑗 = 2, … ,T and i = 1… ,C,Xi𝑗 = d for some 𝑗 = 1, … ,T
for all d = 0, … ,D − 1 and i = 1, … ,C}.
That is, we enforce that each cluster receives interventions 0, 1, and 2. This allows us to perform an assessment of the
advantages optimization that can bring in the likely common case in which it is desired that each cluster receive all of
the interventions. Note that, in this case, certain combinations of C and T considered above are no longer possible (eg, for
T = 2, a cluster cannot receive all three interventions).
We now find that, while the optimal designs are equivalent when using the A- or E-optimality criteria, the D-optimal
designs are distinct. Overall, while the potential efficiency gains that are possible when restricting to these more classical
designs aremoremodest than those in Table 3, they are still substantial. In particular, the admissible designswithw = 0.5
provide a 37.5% reduction in the required number of observations compared to the utilized design. Moreover, we can still
increase the individual power by up to 8.6%.
3.5 D = 3: optimal cross-sectional designs according to the value of the cluster mean
correlation
We have now noted the fact that previous papers have described how the optimal cross-sectional SW-CRT design when
D = 2 changes according to the value of the cluster mean correlation E(𝜌) (where 𝜌 = 𝜌0 = 𝜌1 = 𝜌2 for 𝜎2s = 𝜎2𝜃 = 0).
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TABLE 4 Optimal allocation matrices for cross-sectional designs with D = 3. Several optimal allocation matrices in the case
ℑ = {2, … , 6}, ℭ = {ℭ2, … ,ℭ6}, ℭT = {2, … , 6},𝔐C,T = {2, … , ⌊48∕T⌋}, 𝜎2 = 1, 𝜌 = 0.05, 𝛼 = 0.05 with the Bonferroni correction,
and 𝛽 = 0.12 for the individual power when 𝜹 = (1.5𝜎, 0.75𝜎)⊤ are shown. Specifically, the optimal design for the optimality criteria is
given for w ∈ {0, 0.5}. Restrictions are placed on 𝔛 such that Equation (1) is identifiable and that each cluster must receive each of the
interventions. Each allocation matrix was identified via our exhaustive search method. The utilized design is also shown for comparison
Design
Factor Proposed D-Optimal: w= 0 D-Optimal:w= 0.5 A/E-Optimal: w= 0 A/E-Optimal:w= 0.5
C 6 6 6 6 6
T 6 6 6 6 6
m 8 8 5 8 5
X
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 1 1 2
0 0 0 1 1 2
0 0 1 1 2 2
0 0 1 1 2 2
0 1 1 2 2 2
0 1 1 2 2 2
⎞⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 1 2
0 0 0 0 1 2
0 0 0 1 2 2
0 0 1 2 2 2
0 1 2 2 2 2
0 1 2 2 2 2
⎞⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 1 2
0 0 0 0 1 2
0 0 1 1 2 2
0 1 1 2 2 2
0 1 2 2 2 2
0 1 2 2 2 2
⎞⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 1 2
0 0 0 0 1 2
0 0 1 1 2 2
0 0 1 2 2 2
0 1 2 2 2 2
0 1 2 2 2 2
⎞⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 1 2
0 0 0 0 1 2
0 0 1 1 2 2
0 0 1 2 2 2
0 1 2 2 2 2
0 1 2 2 2 2
⎞⎟⎟⎟⎟⎟⎟⎠
ℙ(Reject H01|𝛿1) 1.0000 1.0000 (±0%) 1.0000 (±0%) 1.0000 (±0%) 1.0000 (±0%)
ℙ(Reject H02|𝛿2) 0.8815 0.9528 (+8.1%) 0.8507 (−3.5%) 0.9570 (+8.6%) 0.8440 (−4.3%)
𝑓 (𝒟 ) 288 288 (±0%) 180 (−37.5%) 288 (±0%) 180 (−37.5%)
det(Λ𝒟 ) 3.090 × 10−3 1.670 × 10−3 (−46.0%) 3.881 × 10−3 (+25.6%) 1.712 × 10−3 (−44.6%) 3.973 × 10−3 (+25.6%)
(D − 1)−1tr(Λ𝒟 ) 5.696 × 10−2 4.264 × 10−2 (−25.1%) 6.392 × 10−2 (+12.2%) 4.160 × 10−2 (−27.0%) 6.373 × 10−2 (+11.9%)
maxDiag(Λ𝒟 ) 5.696 × 10−2 4.264 × 10−2 (−25.1%) 6.531 × 10−2 (+14.7%) 4.160 × 10−2 (−27.0%) 6.373 × 10−2 (+11.9%)
TABLE 5 E-optimal allocation matrices for cross-sectional designs with D = 3. The E-optimal allocation matrices in the case
ℑ = {6}, ℭ = {ℭ6} = {6},𝔐 =𝔐6,6 = {8}, and 𝜎2 = 1, with w = 0 and 𝛽 = 1 are shown for E(𝜌) ∈ {0, 0.01, … , 1}. No
restrictions are placed on 𝔛 other than the identifiability of Equation (1). Each allocation matrix was identified via our
exhaustive search method
Factor E-optimal designs
E(𝜌) {0, … , 0.06} 0.07 {0.08, … , 0.11} {0.12, … , 0.34} {0.35, 0.36} {0.37, … , 0.65}
X
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 0
0 0 0 0 0 1
1 1 1 1 1 1
1 1 1 1 1 1
1 2 2 2 2 2
2 2 2 2 2 2
⎞⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 0
0 0 0 0 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 2 2 2 2
2 2 2 2 2 2
⎞⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 0
0 0 0 0 1 1
0 1 1 1 1 1
1 1 1 1 1 2
1 1 2 2 2 2
2 2 2 2 2 2
⎞⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 0
0 0 0 0 1 1
0 0 1 1 1 1
1 1 1 1 2 2
1 1 2 2 2 2
2 2 2 2 2 2
⎞⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 1
0 0 0 0 1 1
0 0 1 1 1 1
1 1 1 1 2 2
1 1 2 2 2 2
1 2 2 2 2 2
⎞⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 1
0 0 0 0 1 1
0 0 1 1 1 2
0 1 1 1 2 2
1 1 2 2 2 2
1 2 2 2 2 2
⎞⎟⎟⎟⎟⎟⎟⎠
E(𝜌) {0.66, … , 0.83} 0.84 0.85 {0.86, … , 0.94} {0.95, … , 0.99} 1.00
X
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 1
0 0 0 0 1 1
0 0 0 1 1 2
0 1 1 2 2 2
1 1 2 2 2 2
1 2 2 2 2 2
⎞⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 1
0 0 0 0 1 1
0 0 0 1 1 2
0 1 2 2 2 2
1 1 1 2 2 2
1 2 2 2 2 2
⎞⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 1
0 0 0 0 1 2
0 0 0 1 1 1
0 1 1 2 2 2
1 1 2 2 2 2
1 2 2 2 2 2
⎞⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 1
0 0 0 0 1 1
0 0 0 1 2 2
0 0 1 2 2 2
1 1 2 2 2 2
1 2 2 2 2 2
⎞⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 1
0 0 0 0 1 2
0 0 0 1 2 2
0 0 1 2 2 2
0 1 2 2 2 2
1 2 2 2 2 2
⎞⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
1 2 2 2 2 2
1 2 2 2 2 2
1 2 2 2 2 2
⎞⎟⎟⎟⎟⎟⎟⎠
In fact, in Table 1, we provide an example of this for a case with C = 10 and T = 6. In it, we observe that the optimal
design as E(𝜌) increases changes from one resembling a parallel group CRT, to a more classical SW-CRT design. Here, we
provide a brief assessment of whether such a pattern exists for designs with D = 3, in a setting motivated by the SO-HIP
trial. Thus, we set ℑ = {6}, ℭ = {ℭ6} = {6},𝔐 =𝔐6,6 = {8}, 𝜎2 = 1, w = 0, 𝛽 = 1, and
𝔛6,6 = {X ∶ dim(X) = 6 × 6,Xi𝑗 ≥ Xi𝑗−1 for 𝑗 = 2, … , 6 and i = 1… , 6}.
We then consider which design is optimal according to the D-, A-, and E-optimality criteria for E(𝜌) ∈ {0, 0.01, … , 1}.
We present our findings for E-optimality in Table 5 and for D- and A-optimality in the Online Supplementary Material.
Specifically, we can see that, while the pattern to the way in which the optimal X changes is arguably less clear than in
the case with D = 2, there is still a trend that the best possible choice shifts from a longitudinal parallel group CRT, to a
design resembling an extension of a classical SW-CRT.
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TABLE 6 Optimal allocation matrices for cross-sectional designs with D = 4. Several optimal allocation matrices in
the case ℑ = {8}, ℭ = {ℭ6} = {8},𝔐6,8 = {8}, 𝜎2 = 1, 𝜌 = 0.05, 𝛼 = 0.05 with the Bonferroni correction, w = 0, and
𝛽 = 0.12 for the individual power when 𝜹 = (1.5𝜎, 0.75𝜎, 0.75𝜎)⊤ are shown. No restrictions are placed on 𝔛 other than
the identifiability of Equation (1). Each allocation matrix was identified via our stochastic search method. The proposed
design is also shown for comparison
Design
Factor Proposed D-optimal A-optimal E-optimal
X
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 1 1 2 2 3
0 0 0 1 1 2 2 3
0 0 1 1 2 2 3 3
0 0 1 1 2 2 3 3
0 1 1 2 2 3 3 3
0 1 1 2 2 3 3 3
⎞⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 0 1 1
0 0 0 0 1 1 2 3
0 0 1 2 2 3 3 3
0 1 1 1 1 2 2 2
1 2 2 2 3 3 3 3
2 2 3 3 3 3 3 3
⎞⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 0 1 1
0 0 0 0 1 1 3 3
0 0 1 1 1 2 2 2
1 1 1 1 2 2 2 2
1 1 2 2 2 3 3 3
2 2 2 3 3 3 3 3
⎞⎟⎟⎟⎟⎟⎟⎠
⎛⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 0 1 3
0 0 0 0 1 1 2 2
0 0 0 1 1 3 3 3
1 1 1 1 2 2 2 2
1 1 2 2 3 3 3 3
2 2 3 3 3 3 3 3
⎞⎟⎟⎟⎟⎟⎟⎠
ℙ(Reject H01|𝛿1) 1.000 1.000 (±0%) 1.000 (±0%) 1.000 (±0%)
ℙ(Reject H02|𝛿2) 0.852 0.992 (+11.6%) 0.996 (+11.7%) 0.989 (+11.6%)
ℙ(Reject H03|𝛿3) 0.852 0.990 (+11.6%) 0.984 (+11.6%) 0.989 (+11.6%)
det(Λ𝒟 ) 1.559 × 10−4 1.985 × 10−5 (−87.3%) 2.108 × 10−5 (−86.5%) 2.090 × 10−5 (−86.6%)
(D − 1)−1tr(Λ𝒟 ) 5.590 × 10−2 2.873 × 10−2 (−48.6%) 2.806 × 10−2 (−49.8%) 2.886 × 10−2 (−48.4%)
maxDiag(Λ𝒟 ) 5.590 × 10−2 3.024 × 10−2 (−45.9%) 3.085 × 10−2 (−44.8%) 2.893 × 10−2 (−48.2%)
3.6 D= 4: stochastic determination of optimal designs
Finally, we suppose that the SO-HIP study is to actually be conducted with a fourth intervention arm. This hypothetical
trial is to again be conducted in six clusters (C = 6), with eight measurements taken per cluster per period (m = 8), but
will now run across eight periods (T = 8). Furthermore, the following natural extension of the design for D = 3 will be
used for X:
X =
⎛⎜⎜⎜⎜⎜⎝
0 0 0 1 1 2 2 3
0 0 0 1 1 2 2 3
0 0 1 1 2 2 3 3
0 0 1 1 2 2 3 3
0 1 1 2 2 3 3 3
0 1 1 2 2 3 3 3
⎞⎟⎟⎟⎟⎟⎠
.
We assume that the trial will control the familywise error rate to 𝛼 = 0.05 using the Bonferroni correction. Pre-trial,
the variance parameters have been set as 𝜎2 = 1 and 𝜌 = 0.05, and we take 𝜹 = (1.5𝜎, 0.75𝜎, 0.75𝜎)⊤.
We then suppose that we desire to determine howmuch the trials efficiency could be improved if an alternative design
was utilized. For this, we employ a stochastic search, as ℑ = {8}, ℭ = {ℭ8} = {6}, and𝔐 = {𝔐6,8} = {8} with D = 4
confer a design space too large for an exhaustive comparison.
In Table 6, we present the stochastically identified optimal designs for the D-, A-, and E-optimality criteria. We can see
that, in particular, the average variance of our intervention effects could be reduced by up to 49.8% (A-optimality), or the
maximal variance of the intervention effects reduced by up to 48.2% (E-optimality). It is thus clear that a stochastic search
can allow the identification of efficient designs when an exhaustive search would not be feasible.
4 DISCUSSION
We have presented a method to determine admissible MA-SW designs. Our work builds on previous results for SW-CRTs
to allow trialists to determine efficient designs when any linear mixed model is to be used for data analysis and when
there is any number of treatment arms.
For our primary motivating example, the SO-HIP study, we demonstrated for the considered parameters that the indi-
vidual power could have been maintained with the number of required observations reduced by 58%. While for some
possible design parameter combinations, this reduction would likely not be so pronounced, it is clear that admissible
designs in this context could bring notable efficiency gains.
It is important to note, however, that there are some scenarios in which our approach would likely not be applica-
ble. This includes cases where the design space 𝔇 is extremely large, even after C and T have been specified precisely.
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A trialist must then either look to extend the approach of Girling and Hemming19 or look to reduce the size of𝔇 to make
an exhaustive or stochastic search possible.
More significantly, our methodology, like all others on optimal SW-CRT design, assumes that the variance parameters
of the analysis model of interest are known. Accordingly, our approach may not be a wise one when substantial uncer-
tainty exists about their values. When confidence does exist around their specification, it remains important to assess the
sensitivity of the chosen design to the underlying assumptions, using, for example, an approach like that in Section 3.2.
Our methodology is also limited to linear mixed models. For large sample sizes our methods may still be appropriate
for alternate endpoints such as binary or count data, but they would not always be acceptable in these domains. In the
Online Supplementary Material, we provide a brief demonstration of how our methods can be applied to binary outcome
variables. In addition, for some linear mixed models, allowing the number of time periods T to vary may cause issues if a
complex correlation structure is assumed for the accrued responses.
Furthermore, as for any trial, the particular linear mixedmodel used for data analysis should be chosen carefully. Here,
an unwise choice of model could cause problems as the chosen design may not be optimal for an alternative potential
model. More importantly though, as discussed recently by Kasza et al,32 an incorrect choice of correlation structure can
have a significant impact on the sample size required by, and the power of, SW-CRTs. It is easy to envisage this problem
being exacerbated in MA-SWs, given that the presence of multiple interventions may necessitate a highly complex corre-
lation structure. Thus, we highlight again that arguablymore appropriate linearmixedmodels for the analysis of SW-CRT
data than that considered here are supported by our methodology, and we advise that, in general, it would be important
to consider their utilization.
Wemade fewprincipal assumptions about the nature of the trial design.Ourmethod is applicable to both cross-sectional
and cohort studies and to cases where either a single or multiple interventions are allocated to each cluster in each time
period. Nonetheless, from those MA-SW trials conducted so far, it appears that a common likelihood will be that there
is some natural ordering to the interventions. Lyons et al,23 however, do provide a detailed description of alternative
possibilities to this.
In Section 3, we employed several different types of restrictions on the sets𝔛C,T . In particular, we demonstrated that our
approach can be easily applied to attain classical designs where the clusters receive all interventions and to cases where
there must be equal allocation to sequences. In general, not placing restrictions on𝔛C,T , beyond those that are absolutely
required, will result in the determination of the most efficient design. However, particularly through Table 4, we were
able to demonstrate that optimization is still useful when such restrictions are considered necessary.
Finally, it is important to discuss the fact that, in practice, a choice must be made around which optimality criteria to
use and what value to use for w. Unfortunately, there is no simple solution to this. Previous authors have highlighted that
D-optimality is an easy quantity to explain to practitioners frommany fields.31 However, it is difficult to claim that A- and
E-optimality would be more complex to describe. Arguably, A-optimality is most useful when the parameters of interest
are of equal importance. In contrast, D- and E-optimality may favor more specialized considerations. However, note that
in certain situations, as in Table 1, we may find that the optimal design for each of these criteria is equivalent. Thus, such
a choice may not always be required. Finally, when choosingw, if gathering observations is cheap, we may anticipate that
setting w approximately equal to 0 is logical. This would also be the case when we have a fixed number of observations
in mind, and simply want to optimize X, as in many of the discussions in Section 3. Most typically though, it is likely we
would need to find a balance between cost and efficiency. In this case, larger values of w would seem appealing. But, we
would rarely recommend setting w = 1, as even placing a tiny weight on the D-, A-, or E- optimality criteria can result
in the choice of a much more efficient X, for only slightly increased cost.
In conclusion, we have presented methodology to identify highly efficient MA-SWs. Of course, the most important
factor for any real trial is that a design and analysis procedure are chosen that are appropriate for the complexities of the
data the trial will likely accrue. However, when logistical, practical, and statistical, constraints permit the possibility to
use one of a range of designs, researchers should consider the use of our approach to optimize their trials efficiency. As
we have demonstrated, restrictions can readily be placed on the sets 𝔛C,T to retain the needs of the trial but still allow
more efficient designs to be identified.
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